The aim of this session is to introduce the new trials which are using biomarkers of classification and/or personalized features to identify best candidate patients and deliver precision treatment. Trial designs and available results will be presented.

Agenda:

• TREM-1 Pathway
• ARDS: Room for Precision Treatment?
• Modulation of Complement
• Macrolides for Community-Acquired Pneumonia
• Reversal of Immunoparalysis

The speakers are internationally-recognized experts chosen by the World Sepsis Alliance Scientific Advisor Committee:

• Maha Aljuaid, Eastern Mediterranean Sepsis Alliance, Saudi Arabia
• Bruno Francois, Dupuytren University Hospital, France
• Carolyn Calfee, University of California, San Francisco Medical Center, United States of America
• Alexander Vlaar, Amsterdam UMC, The Netherlands
• Michael Niederman, Weill Cornell Medicine, United States of America
• Sara Cajander, Örebro University, Hospital, Sweden